Brief: IVD Medical Announces Signing Of Strategic Cooperation Agreement With Transcenta Holding
22/09/2025 02:14
Sept 22 (Reuters) - Ivd Medical Holding Ltd 1931.HK: SIGNING OF STRATEGIC COOPERATION AGREEMENT WITH TRANSCENTA HOLDING AGREEMENT ON RWA TOKENIZATION- OF ASSETS FOR US$1.5 BILLION INNOVATIVE DRUG PIPELINES Further company coverage: 1931.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcenta Holding
See all newsBrief: Transcenta Says Global Phase III Trial Of Osemitamab Approved By FDA, China, Korea Regulators
Brief: Transcenta Holding Says Unit To Sell CDMO Assets For RMB190.0 Million
Brief: Transcenta Holding To Revert Assets To Lilly For $4 Million Cash
Brief: Transcenta Therapeutics Appoints Dr. Christopher Hwang As Head Of Global Partnerships For Hicb Platform
Brief: Transcenta Announces Collaboration And Non-Exclusive Licensing Agreement With Eirgenix Inc.